newsfilter
← Latest News
GlobeNewswire·

Harpoon Therapeutics Announces Acceptance of Five Abstracts for Presentation at AACR Annual Meeting 2023

Preclinical abstracts for investigational T cell engagers, HPN328 and HPN217, in mouse models provide further validation of Harpoon's proprietary Tri-specific T cell Activating Construct (TriTAC®) platform and